Dual Clinical Efficacy of NLX-112 in Parkinson’s Disease Presented at Scientific Meetings August 22, 2023 Off Uncategorized, Ground-breaking Non-Dopaminergic Drug Combining Both Anti-Dyskinetic and Anti-Parkinsonian Properties The positive effects on both LID...